Naloxone Injectable 0.4 mg (Naloxone Hydrochloride SOLUTION) 0.4 MG

Naloxone Injectable 0.4 mg is a medication used to counteract opioid overdose effects. This injectable solution is designed for emergency use and is manufactured by Hikma Canada Limited.

Strength

0.4 MG

Manufacturer / TM Owner

HIKMA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Naloxone Injectable 0.4 mg is primarily used in emergency situations to reverse the effects of opioid overdose. It works by blocking the effects of opioids in the brain, which can help restore normal breathing in individuals who have overdosed. This medication is often administered by healthcare professionals or trained individuals in critical situations. What is naloxone used for? It is specifically indicated for the treatment of opioid overdose, including respiratory depression caused by opioids.

Side Effects

Common effects of Naloxone Injectable 0.4 mg include rapid reversal of opioid-induced respiratory depression. Users may experience symptoms such as sweating, nausea, and vomiting as the medication works to counteract the effects of opioids. In some cases, individuals may also feel agitated or anxious. These effects are typically temporary and subside as the medication's effects wear off.

Precautions & Warnings

Naloxone Injectable 0.4 mg should be handled with care and stored properly to maintain its effectiveness. It is important to follow the instructions provided by healthcare professionals regarding administration and storage. Individuals with known allergies to naloxone or any of its components should avoid using this medication. Always consult a healthcare provider for personalized advice.

Avoid Interactions

Naloxone Injectable 0.4 mg may interact with other medications, particularly those that affect the central nervous system. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and other sedatives should be used with caution, as they may exacerbate the effects of opioids that naloxone is intended to counteract.

Frequently Asked Questions

Naloxone Injectable 0.4 mg is used to reverse the effects of opioid overdose, particularly respiratory depression.

Naloxone Injectable 0.4 mg is typically administered intramuscularly by healthcare professionals or trained individuals.

Common side effects include sweating, nausea, vomiting, agitation, and anxiety.

No, naloxone is not used for pain relief; it is specifically indicated for the treatment of opioid overdose.

Individuals with known allergies to naloxone or any of its components should avoid using this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.